Korsana Biosciences, Inc.
KRSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001755237
No open-market purchases or sales by Korsana Biosciences, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $11.2M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Korsana Biosciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −8 vs. Q1 2022
- Shares held
- 20.9M
- −2.05M (−8.9%) vs. Q1 2022
- Total value
- $11.5M
- −$14.0M (−55.0%) vs. Q1 2022
- New holders
- 4
- 8 more added
- Sold out
- 12
- 12 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $11.2M |
| Q1 2026 | 17 | $249.0K |
| Q4 2025 | 19 | $376.3K |
| Q3 2025 | 17 | $595.4K |
| Q2 2025 | 17 | $1.06M |
| Q1 2025 | 18 | $931.7K |
| Q4 2024 | 19 | $1.23M |
| Q3 2024 | 15 | $2.70M |
| Q2 2024 | 17 | $2.41M |
| Q1 2024 | 15 | $3.42M |
| Q4 2023 | 15 | $3.58M |
| Q3 2023 | 17 | $3.66M |
| Q2 2023 | 18 | $4.10M |
| Q1 2023 | 34 | $8.95M |
| Q4 2022 | 40 | $13.7M |
| Q3 2022 | 38 | $18.3M |
| Q2 2022 | 41 | $11.5M |
| Q1 2022 | 50 | $25.6M |
| Q4 2021 | 56 | $40.7M |
| Q3 2021 | 62 | $75.8M |
| Q2 2021 | 68 | $96.0M |
| Q1 2021 | 71 | $62.5M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Korsana Biosciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $3.93M | 0.25% | 00.0% | Unchanged |
| MFN Partners Management, LP | 3,389,215 | $1.86M | 0.08% | 00.0% | Unchanged |
| Artal Group S.A. | 2,779,122 | $1.52M | 0.08% | 00.0% | Unchanged |
| FMR LLC | 2,537,723 | $1.39M | 0.00% | −77,287−3.0% | Reduced |
| Vanguard Group Inc | 1,754,153 | $963.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 573,694 | $314.0K | 0.00% | −9,689−1.7% | Reduced |
| Renaissance Technologies LLC | 456,077 | $250.0K | 0.00% | +153,519+50.7% | Added |
| BlackRock Inc. | 361,580 | $198.0K | 0.00% | −79,800−18.1% | Reduced |
| Trustcore Financial Services, LLC | 292,645 | $161.0K | 0.01% | 00.0% | Unchanged |
| Diametric Capital, LP | 243,539 | $134.0K | 0.10% | +60,609+33.1% | Added |
| Acadian Asset Management LLC | 231,952 | $127.0K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 126,192 | $69.0K | 0.00% | +25,937+25.9% | Added |
| State Street Corp | 115,414 | $63.0K | 0.00% | −135−0.1% | Reduced |
| Bridgeway Capital Management, LLC | 115,000 | $63.0K | 0.00% | 00.0% | Unchanged |
| Colony Group LLC | 102,884 | $57.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 96,700 | $53.0K | 0.00% | −118,400−55.0% | Reduced |
| Northern Trust Corp | 80,792 | $44.0K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 77,993 | $43.0K | 0.00% | −37,649−32.6% | Reduced |
| Jane Street Group, LLC | 58,292 | $32.0K | 0.00% | +58,292 | New |
| Two Sigma Securities, LLC | 54,638 | $30.0K | 0.01% | +54,638 | New |
| Prudential Financial Inc | 52,270 | $29.0K | 0.00% | +52,270 | New |
| Millennium Management LLC | 51,589 | $28.0K | 0.00% | −103,617−66.8% | Reduced |
| Intrinsic Value Partners, LLC | 48,315 | $27.0K | 0.03% | −1,600−3.2% | Reduced |
| Mackenzie Financial Corp | 40,920 | $22.0K | 0.00% | +15,611+61.7% | Added |
| Susquehanna International Group, LLP | 31,956 | $18.0K | 0.00% | +12,124+61.1% | Added |
| Verition Fund Management LLC | 20,000 | $11.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 18,368 | $10.0K | 0.00% | +100+0.5% | Added |
| Tower Research Capital LLC (TRC) | 13,569 | $8.00K | 0.00% | −3,891−22.3% | Reduced |
| Davenport & Co LLC | 13,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,251 | $3.00K | 0.00% | −33,934−86.6% | Reduced |
| High Net Worth Advisory Group LLC | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 3,390 | $1.00K | 0.00% | +3,390 | New |
| BNP Paribas Arbitrage, SA | 317 | $174 | 0.00% | +30+10.5% | Added |
| Bank of America Corp | 29 | $0 | 0.00% | −2,442−98.8% | Reduced |
| Wells Fargo & Company | 400 | $0 | 0.00% | +24+6.4% | Added |
| Royal Bank of Canada | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 27 | $0 | 0.00% | −100−78.7% | Reduced |
| Clean Yield Group | 115 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 297 | $0 | 0.00% | 00.0% | Unchanged |
| Coastal Capital Group, Inc. | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Concord Wealth Partners | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −776,497−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −527,462−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −371,955−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −122,249−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −66,512−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −50,761−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −45,058−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −42,400−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −10,149−100.0% | Sold out |
| Sawyer & Company, Inc | 0 | $0 | 0.00% | −4,100−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,645−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |